MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$4,138K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
3,082
2,793
1,281*
1,181
General and administrative
1,186
1,374
764*
1,324
Total operating expenses
4,268
4,167
2,044
2,505
Operating loss
-4,268
-4,167
-2,044*
-2,505
Interest income, net
130
161
181*
113
Other income (expense), net
0
3
2*
0
Net loss
-4,138
-4,003
-1,861
-2,392
Basic EPS
-0.36
-0.34
-0.242
-0.44
Basic Average Shares
11,617,250
11,617,250
7,688,610
5,468,584
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$4,138K
(-91.04%↓ Y/Y)
Interest income, net
$130K
Operating loss
-$4,268K
(-84.84%↓ Y/Y)
Total operating
expenses
$4,268K
(84.84%↑ Y/Y)
Research and development
$3,082K
(186.96%↑ Y/Y)
General and
administrative
$1,186K
(-3.97%↓ Y/Y)
Buy us a coffee
Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Corp. (PHIO)